FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/054060 [Registered on: 16/06/2023] Trial Registered Prospectively
Last Modified On: 15/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic
Preventive 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Dashmoolaadi kwatha in bronchial asthma(tamak shwasa) 
Scientific Title of Study   Clinical evaluation of dashmoolaadi kwatha with & without virechana in tamak shwasa  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Someen Pant 
Designation  Pg scholar 
Affiliation  Uttarakhand Ayurveda University, Gurukul campus, Haridwar  
Address  OPD 5 PG department of kayachikitsa, Uttarakhand Ayurveda University,Gurukul campus, Haridwar

Hardwar
UTTARANCHAL
249404
India 
Phone  8755245692  
Fax    
Email  pant.drsomeen02@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dinesh Kumar Goyal 
Designation  Professor  
Affiliation  Uttarakhand Ayurveda University ,Gurukul campus, Haridwar 
Address  OPD 5 PG Department of kayachikitsa, Uttarakhand Ayurveda University, Gurukul Campus, haridwar

Hardwar
UTTARANCHAL
249404
India 
Phone  9411731180  
Fax    
Email  dineshdr157@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Someen Pant 
Designation  Pg scholar  
Affiliation  Uttarakhand Ayurveda University 
Address  OPD 5 PG department of kayachikitsa, Uttarakhand Ayurveda University,Gurukul campus, Haridwar

Hardwar
UTTARANCHAL
249404
India 
Phone  8755245692  
Fax    
Email  pant.drsomeen02@gmail.com  
 
Source of Monetary or Material Support  
UAU Gurukul Campus, haridwar 
 
Primary Sponsor  
Name  Someen pant  
Address  OPD 05 PG department of kayachikitsa, Uttarakhand Ayurveda University,Gurukul campus, haridwar 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Someen pant  UAU,Gurukul campus, haridwar  OPD 5 PG Department of kayachikitsa, UAU,Gurukul campus, haridwar
Hardwar
UTTARANCHAL 
8755245692

pant.drsomeen02@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC UAU Gurukul Campus   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J00-J99||Diseases of the respiratory system. Ayurveda Condition: TAMAKASVASAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Dashmooladi kwatha, Reference: charaka chikitsa 17/ 102-103, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: dashmooladi kwatha after virechana , Reference: charaka chikitsa 17/ 102-103, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient having classical features of Tamak Shwasa as mentioned in classics.
Male or female between the age group 18-60 years.
Patient fit for Virechana.

 
 
ExclusionCriteria 
Details  Patients below 18 years and above 60 years.
Bronchial asthma associated with complications like emphysema,cor-pulmonale etc.
Patient suffering from Pulmonary tuberculosis, Lung cancer, Lung fibrosis,Bronchitis
Severe attack of asthma
Cardiac disease like cardiac asthma, IHD etc.
Patient suffering from other major medical and psychiatric disorders. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Shayanah shwasa pidatah (Breathlessness during lying position)
Aasinolabhate saukhyam (comfort in sitting posture)
Shleshmanayamuchyamane tu bhrisham bhavati dukhitah (difficult to expectorate)
shleshma Vimokshante Muhurtam labhate sukham (momentary releif after expectoration)
Shwasakrichta (difficulty in breathing)
Ghurgurukam (wheezing sound)
Parsve Avagruhyate (chest tightness)
Ativega kasate (frequent bouts coughing)
 
At 1st, 15th & 45th day 
 
Secondary Outcome  
Outcome  TimePoints 
Peak expiratory flow rate
Oxygen saturation
Absolute Eosinophil Count(AEC)
ESR 
At 1st 15th 45th day 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is a open label,randomized,parallel group clinical
 trial to determine the efficacy of dashmoolaadi kwatha with and without virechana in tamak shwasa (Bronchial Asthma) for the age group between 18-60 years for 45 days.Study will be conducted at UAU, Gurukul Campus, Haridwar on 40 patients. Assessment will be done on the basis of subjective and objective parameters. Study will be conducted at OPD/IPD level of PG department of Kayachikitsa. Assessment will be done at the interval of 15 days of clinical trial and result obtained will be  tabulated and statistically analyzed using appropriate tests 
 
Close